daunorubicin has been researched along with doxoform in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fenick, DJ; Koch, TH; Taatjes, DJ | 3 |
3 other study(ies) available for daunorubicin and doxoform
Article | Year |
---|---|
Doxoform and Daunoform: anthracycline-formaldehyde conjugates toxic to resistant tumor cells.
Topics: Alkylation; Catalysis; Chromatography, High Pressure Liquid; Daunorubicin; Dimerization; DNA; Doxorubicin; Drug Resistance, Neoplasm; Formaldehyde; Humans; Hydrolysis; Mass Spectrometry; Models, Chemical; Oxazoles; Tumor Cells, Cultured | 1997 |
Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.
Topics: Antibiotics, Antineoplastic; Cell Division; DNA Adducts; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Humans; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Magnetic Resonance Spectroscopy; Mass Spectrometry; Oligonucleotides; Tumor Cells, Cultured | 1998 |
Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
Topics: Alkylation; Antineoplastic Agents; Cell Nucleus; Daunorubicin; DNA, Neoplasm; Doxorubicin; Epirubicin; Formaldehyde; Humans; RNA, Neoplasm; Spectrometry, Fluorescence; Tumor Cells, Cultured | 1999 |